Intercept Pharmaceuticals Inc Ret. on equity
What is the Ret. on equity of Intercept Pharmaceuticals Inc?
The Ret. on equity of Intercept Pharmaceuticals Inc is -82.24%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Health Care sector on NASDAQ compared to Intercept Pharmaceuticals Inc
What does Intercept Pharmaceuticals Inc do?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Companies with ret. on equity similar to Intercept Pharmaceuticals Inc
- Long Term Care Operations 360 has Ret. on equity of -82.32%
- Long Term Care Operations 360 has Ret. on equity of -82.32%
- Redwood Green has Ret. on equity of -82.32%
- Moxian (BVI) Inc has Ret. on equity of -82.30%
- LATAM Airlines S.A has Ret. on equity of -82.28%
- Code Chain New Continent has Ret. on equity of -82.26%
- Intercept Pharmaceuticals Inc has Ret. on equity of -82.24%
- Austpac Resources N.L has Ret. on equity of -82.20%
- China Wood Optimization () has Ret. on equity of -82.20%
- Anacott Acquisition has Ret. on equity of -82.15%
- Mirati Therapeutics Inc has Ret. on equity of -82.15%
- Huazhang Technology has Ret. on equity of -82.00%
- Yuma has Ret. on equity of -81.89%